Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment ...Middle East

DOVER, Del. and EPALINGES, Switzerland, Dec. 10, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecule, PLT012, for treating liver and intrahepatic bile duct cancer...

Read More Details
Finally We wish PressBee provided you with enough information of ( Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment )

Also on site :

• Israeli forces halt aid boat carrying Greta Thunberg and detain activists
• Integrated ancient city uncovered in Karnak, dating back to 2000 BC
• Ukraine doing West’s ‘dirty work’ in Africa – Sudanese official